1-15 of 59004 results
Impax introduces authorized generic of Zomig in US
Impax Laboratories has introduced authorized generic of Zomig (zolmitriptan) tablets and orally disintegrating tablets, 2.5mg and 5mg, in the US.
Drug Research > Drug Discovery & Development > News
Drug Research > Drug Discovery & Development > News
Cellular enrolls 50% patients in Phase I knee osteoarthritis trial
Cellular Biomedicine has achieved 50% enrollment milestone in Phase I open label clinical research trial for knee osteoarthritis (KOA).
Contract Research & Services > Clinical Trials > News
Contract Research & Services > Clinical Trials > News
ImmunoCellular obtains US patent covering use of interleukin 13-receptor alpha 2 protein
ImmunoCellular Therapeutics has obtained US patent for methods of use of interleukin 13-receptor alpha 2 protein (IL-13Rα2) in cancer immunotherapy.
Regulatory Affairs > News
Regulatory Affairs > News
DBV, Stallergenes sign strategic research partnership targeting respiratory allergies
DBV Technologies and Stallergenes have signed a strategic research partnership for the development of new treatment of respiratory allergies.
Contract Research & Services > Contract Research > News
Contract Research & Services > Contract Research > News
RuiYi, Genor sign RYI-008 development deal in China
RuiYi and Genor BioPharma have signed an exclusive license and collaborative development agreement for RYI-008 in China.
News
News
Novo Nordisk reports positive results from Phase-3 haemophilia B study of N9-GP
Novo Nordisk has reported positive results from Phase-3 study of FIX derivative N9-GP to treat haemophilia B.
Contract Research & Services > Clinical Trials > News
Contract Research & Services > Clinical Trials > News
NW Bio Phase III trial with DCVax-L for brain cancer commences at King's College Hospital
Northwest Biotherapeutics (NW Bio) has announced that the King's College Hospital in the UK commenced Phase III trial with DCVax-L for brain cancer.
Contract Research & Services > Clinical Trials > News
Contract Research & Services > Clinical Trials > News
SciClone, Zensun enter into agreement for Neucardin in China
SciClone Pharmaceuticals has entered into an agreement with Zensun granting SciClone a license and exclusive rights in China, for the promotion and sale of Neucardin.
Contract Research & Services > Contract Services > News
Contract Research & Services > Contract Services > News
Almac secures BBSRC programme with UCL
UK-based Almac biocatalysis has secured a Biotechnology and Biological Sciences Research Council (BBSRC) programme with University College London (UCL) aimed at metagenomics and novel enzyme discovery.
Drug Research > Drug Discovery & Development > News
Drug Research > Drug Discovery & Development > News
UCB, IBM collaborate on super-computer project to improve epilepsy care
UCB and IBM have announced the completion of the initial phase of project designed to exploit super-computer power for better care for epilepsy patients.
Automation > IT & Software > News
Automation > IT & Software > News
Trillium Therapeutics completes dosing in Phase I study of TTI-1612
Trillium Therapeutics, a wholly owned subsidiary of Stem Cell Therapeutics, has completed dosing of patients with interstitial cystitis/bladder pain syndrome (IC/BPS) in first phase study of TTI-1612.
Contract Research & Services > Clinical Trials > News
Contract Research & Services > Clinical Trials > News
Evotec, Harvard to jointly develop new class of antibacterials
Evotec and Harvard University have entered into research collaboration to develop new class of antibacterials.
Drug Research > Drug Discovery & Development > News
Drug Research > Drug Discovery & Development > News
Helsinn, Vifor sign distribution deal for netupitant-palonosetron fixed dose combination
Helsinn Healthcare and Vifor Pharma have signed a licensing and distribution deal for netupitant-palonosetron fixed dose combination (NEPA) in Switzerland, France, Spain, Portugal, the Netherlands, Belgium and Luxembourg.
Contract Research & Services > Contract Services > News
Contract Research & Services > Contract Services > News
Alethia gains US patent for cancer treatment methods
Alethia Biotherapeutics has gained US patent for methods of treating carcinomas with antibodies targeting the region of secreted clusterin (sCLU) responsible for promoting epithelial-to-mesenchymal transition (EMT).
Regulatory Affairs > News
Regulatory Affairs > News
Bayer to acquire Steigerwald Arzneimittelwerk
Bayer has signed an agreement to purchase 100% of the shares of Steigerwald Arzneimittelwerk.
Inward Investment > News
Inward Investment > News
PBR Supplier Recommendations
FormPipe Software provides information quality management systems for companies operating within strict GxP regulatory environments such as pharmaceutical and medical device, enabling companies to capture, process, store, archive, and supply information in a systemised and controlled manner. The company is a leading provider of ECM (Enterprise Content Management) in Europe with their HQ in Stockholm, Sweden.... Automation > IT & Software > Suppliers Polygon Medical Animation - 3D Medical Animation, Illustration and Interactive
Polygon is the full-service global provider of high-end MOA mechanism of action 3D medical animation and Illustration for the Pharma and Biotech industry, as well as educational institutes worldwide. ... Drug Research > Drug Discovery & Development > Suppliers Parchem - fine & specialty chemicals
Parchem is the leading global supplier of specialty raw materials. Our expertise lends itself to servicing the pharmaceutical and specialty chemicals industries. Innovative technology, global sourcing and custodial supply chain management are the core tenets of Parchem's business model. As a leading supplier we are committed to the highest integrity of customer centric services and sourcing of the most difficult to find raw materials in the world.... Production & Manufacturing > Fine & Speciality Chemicals > Suppliers Lallemand Pharma - Lyophilized Bacterial Lysates for Immuno-Protection Solutions
Based in Zug (Switzerland), Lallemand Pharma International (LPI) is a pharmaceutical subsidiary of the Lallemand group. LPI is in charge of the business and possesses the intellectual property rights of an oral vaccine indicated in the prevention of respiratory infections known as PMBL™ . ... Contract Research & Services > Contract Research > Suppliers DVS Quality Solutions Limited - Securing the Pharmaceutical Packaging Workflow
DVS was formed in 2005 to help ensure that Pharmaceutical Packaging is fit for purpose in terms of content and specification. The primary focus of the Company is to ensure that clients packaging contains the correct information, and that there are no unwanted changes throughout the packaging development process. ... Automation > IT & Software > Suppliers See more
PBR White Paper Recommendations
For high speed in-line sanitation of cups, lids etc the optimal UV equipments are U-shaped amalgam low pressure Mercury vapor lamps. Sterilization at the same or at lower production rates requires pulsed UV light systems. The selection method is illustrated by results and data from manufacturers.... Production & Manufacturing > Process & Production > White Papers Bag-on-Valve Overview 10 May 2013 | By Aurena Laboratories
The Bag-on-Valve (BoV) technology is gaining in popularity, especially for cosmetics and healthcare applications. The packaging technology is used in aerosol cans; i.e. Cans containing liquid or viscous products that are sprayed during administration and where the actual dispensing is propelled by a compressed gas.... White Papers Assessment of the Impact of the European Pharmacopoeia Monograph for Norflurane 09 May 2013 | By Mexichem Fluor
A draft monograph for HFA 134a (norflurane) was first published in the April 2011 edition of PHARMAEUROPA (Volume 23, No.2), with the usual period for comment and review. Mexichem Fluor provided comments on this draft via the appropriate national pharmacopoeia authority, in this case the British Pharmacopoeia. The final monograph was included in Supplement 7.7 (published 1 October 2012) to the 7th Edition of European Pharmacopoeia (Ph Eur). Supplement 7.7 has an implementation date of 1 April 2013.... Production & Manufacturing > Fine & Speciality Chemicals > White Papers The Pulse on Study Conduct -- Best Practices and Critical Strategies to Ensure Site Success 24 April 2013 | By CenterWatch
Industry expert Elizabeth Blair Weeks-Rowe offers solutions to achieve study conduct success from ensuring clean data to preparing for a co-monitoring visit. ... Contract Research & Services > Clinical Trials > White Papers The Pulse on Recruitment -- Exploring the Use of Social Media and Online Tactics in Patient Recruitment 24 April 2013 | By CenterWatch
Industry experts Cara Danchak and Bonnie A. Brescia offer insight into the challenges and potential benefits of social media and online patient recruitment.... Contract Research & Services > Clinical Trials > White Papers See more